What to Like -- and Dislike -- About Boston Scientific's Q4 Results
You might say that Boston Scientific (NYSE: BSX) delivered an average performance in 2019. But while the stock delivered a gain that nearly exactly matched that of the S&P 500 index last year, it's hard to look at a 28% jump as just average.
This year hasn't started off as positively for the medical device maker, though. But Boston Scientific announced its fourth-quarter results before the market opened on Wednesday, giving investors some good news -- along with some news that wasn't as good. Here are the highlights from the company's Q4 update.
Image Source: Getty Images.
Source Fool.com
